[go: up one dir, main page]

AU2002211776A1 - A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes - Google Patents

A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes

Info

Publication number
AU2002211776A1
AU2002211776A1 AU2002211776A AU1177602A AU2002211776A1 AU 2002211776 A1 AU2002211776 A1 AU 2002211776A1 AU 2002211776 A AU2002211776 A AU 2002211776A AU 1177602 A AU1177602 A AU 1177602A AU 2002211776 A1 AU2002211776 A1 AU 2002211776A1
Authority
AU
Australia
Prior art keywords
retinamide
liposomes
hydroxyphenyl
incorporate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211776A
Inventor
Soo-Jeong Lim
Gabriel Lopez-Berestein
Ana Maria Tari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU2002211776A1 publication Critical patent/AU2002211776A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002211776A 2000-10-17 2001-10-17 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes Abandoned AU2002211776A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24144500P 2000-10-17 2000-10-17
US60/241,445 2000-10-17
PCT/US2001/032310 WO2002032413A2 (en) 2000-10-17 2001-10-17 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes

Publications (1)

Publication Number Publication Date
AU2002211776A1 true AU2002211776A1 (en) 2002-04-29

Family

ID=22910729

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211776A Abandoned AU2002211776A1 (en) 2000-10-17 2001-10-17 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes

Country Status (5)

Country Link
US (1) US20020143062A1 (en)
EP (1) EP1328262A2 (en)
AU (1) AU2002211776A1 (en)
CA (1) CA2425196A1 (en)
WO (1) WO2002032413A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169819B2 (en) * 2000-12-05 2007-01-30 Childrens Hospital Los Angeles Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
CA2509955A1 (en) * 2002-11-29 2004-06-17 Gpc Biotech Ag Formulations useful against hepatitis c virus infections
WO2004069203A2 (en) * 2003-01-31 2004-08-19 Childrens Hospital Los Angeles Research Institute Oral compositions of fenretinide having increased bioavailability and methods of using the same
JP4855396B2 (en) 2004-06-23 2012-01-18 リビジョン セラピューティクス， インコーポレイテッド Methods and compositions for treating ophthalmic conditions with retinal derivatives
EP1804788A4 (en) * 2004-10-25 2008-05-21 Sirion Therapeutics Inc Detection and analysis of ophthalmically-relevant fluorescent molecules
AU2005304822B2 (en) * 2004-11-04 2008-10-16 Sirion Therapeutics, Inc. Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation
PT2727583T (en) 2004-12-22 2021-12-27 Nitto Denko Corp Drug carrier and drug carrier kit for inhibiting fibrosis
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
JP2008536874A (en) 2005-04-15 2008-09-11 ボード オブ リージェンツ ザ ユニバーシティー オブ テキサス システム Delivery of siRNA by neutral lipid composition
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITRIC OXIDE-LIBERATING PARTICLES FOR NITRIC OXIDE THERAPY AND BIOMEDICAL APPLICATIONS
UA81382C2 (en) * 2005-07-11 2007-12-25 Composition for treating retinol-related diseases by modulation of retinol binding
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
JP5342834B2 (en) * 2008-09-05 2013-11-13 日東電工株式会社 Treatment agent for myelofibrosis
JP5113038B2 (en) * 2006-03-23 2013-01-09 テムリック株式会社 Cancer treatment kit and pharmaceutical composition for cancer treatment
EP2013016B8 (en) 2006-03-29 2014-10-08 Wayne State University Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
US20080025972A1 (en) * 2006-07-26 2008-01-31 Duke University Treating sex steriod responsive disorders
TWI407971B (en) * 2007-03-30 2013-09-11 Nitto Denko Corp Cancer cells and tumor-related fibroblasts
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
BR112012003792B1 (en) 2009-08-21 2020-05-19 Novan Inc topical composition, and, use of topical composition
US20120121691A1 (en) * 2010-11-15 2012-05-17 Texas Tech University System Method for Increasing the Production of a Specific ACYL-Chain Dihydroceramide(s) for Improving the Effectiveness of Cancer Treatments
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (en) 2011-02-28 2019-01-02 Novan Inc Silica particles modified with S-nitrosothiol that release nitric oxide and methods of manufacturing them
MX372738B (en) * 2013-12-23 2020-05-06 Dermopartners S L PROCEDURE FOR PREPARING LIPOSOMES OF RETINALDEHYDE OR OTHER PRECURSORS OF RETINOIC ACID AND PRODUCT THUS OBTAINED.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
ATE173615T1 (en) * 1992-01-16 1998-12-15 Univ Texas FORMULATION AND USE OF CAROTENOIDS IN CANCER TREATMENT
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders

Also Published As

Publication number Publication date
CA2425196A1 (en) 2002-04-25
WO2002032413A3 (en) 2003-03-27
US20020143062A1 (en) 2002-10-03
WO2002032413A2 (en) 2002-04-25
EP1328262A2 (en) 2003-07-23

Similar Documents

Publication Publication Date Title
AU2002211776A1 (en) A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
AU2001232210A1 (en) Scheduling in a remote-access server
AU2001259059A1 (en) Beta-glucans encapsulated in liposomes
GB2368403B (en) Improvements in or relating to a head-up display
AU2001236954A1 (en) Browser oriented method to view database structures
AUPQ683100A0 (en) A method and system for advertising to a user
GB2385703B (en) A sign
AU147221S (en) A trimmer
AU2002216596A1 (en) Method relating to positioning of a mobile device
AUPQ782400A0 (en) A sleep study apparatus
GB2360322B (en) Improvements relating to fasteners
AU2001285396A1 (en) A magnetic head
GB0005245D0 (en) Improvements in or relating to a razor
AU2001289677A1 (en) Machine unit comprising a drive and a machine
AU147222S (en) A trimmer
GB2363402B (en) Improvements to fencing/reusable fencing
AU2001290111A1 (en) Instruction issue in a processor
AU2001289135A1 (en) Techniques to implement one-dimensional compression
AU5896201A (en) A method to measure surface structure
GB0110677D0 (en) Improvements in or relating to a razor
GB0110675D0 (en) Improvements in or relating to a razor
AU2002309389A1 (en) Improvements in or relating to a pole
AU2001284595A1 (en) A casing and a method to produce the same
AU2001260200A1 (en) Novel alpha-sulfin- and alpha-sulfonamino acid amides
AU2002301555A1 (en) A frame member